KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Payables (2017 - 2025)

Guardant Health's Payables history spans 9 years, with the latest figure at $54.4 million for Q4 2025.

  • For Q4 2025, Payables rose 41.22% year-over-year to $54.4 million; the TTM value through Dec 2025 reached $54.4 million, up 41.22%, while the annual FY2025 figure was $54.4 million, 41.22% up from the prior year.
  • Payables for Q4 2025 was $54.4 million at Guardant Health, up from $20.1 million in the prior quarter.
  • Across five years, Payables topped out at $205.3 million in Q3 2023 and bottomed at $15.5 million in Q3 2024.
  • The 5-year median for Payables is $39.7 million (2022), against an average of $65.1 million.
  • The largest annual shift saw Payables surged 900.1% in 2022 before it plummeted 92.46% in 2024.
  • A 5-year view of Payables shows it stood at $17.6 million in 2021, then soared by 900.1% to $175.8 million in 2022, then crashed by 70.57% to $51.7 million in 2023, then dropped by 25.49% to $38.6 million in 2024, then surged by 41.22% to $54.4 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Payables are $54.4 million (Q4 2025), $20.1 million (Q3 2025), and $44.8 million (Q2 2025).